Events

Talking Point - 21st August 2024, 1pm - 2pm - ONLINE MOXY:  An open label pilot study of oxytocin for methamphetamine withdrawal in women, presented by Dr Sarah Catchlove, Research Fellow, Turning Point & A/Prof Shalini Arunogiri, Clinical Director, Turning Point Statewide Services.  This presentation will provide an overview of the results of a recently completed

It's important to note that BreakThrough is an education program and while each session includes group discussion about a particular topic or theme, people requiring more intensive support in relation to their own circumstances are strongly encouraged to contact Family Drug and Gambling Help on 1300 660 068 to speak to a trained volunteer with